Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms by Site
×
durvalumab
×
Clear all
Filters
3
NCT06606847
2026-03-18
LADOGA
AstraZeneca
Phase 2
Active not recruiting
30 enrolled
NCT05941897
2026-03-05
LOTOS
AstraZeneca
Phase 2
Active not recruiting
39 enrolled
NCT05063565
2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT06463665
2025-09-26
VIRO-25
Genelux Corporation
Phase 2
Recruiting
142 enrolled